Salvage surgery for advanced non-small cell lung cancer following previous immunotherapy: a retrospective study

BACKGROUND: The development of systemic chemotherapy including immune checkpoint inhibitors (ICIs) has provided patients with unresectable advanced non-small cell lung cancer (NSCLC) an opportunity to undergo surgical intervention after initial treatment. However, no consensus regarding the indicati...

Descripción completa

Detalles Bibliográficos
Autores principales: Higuchi, Mitsunori, Inomata, Sho, Yamaguchi, Hikaru, Saito, Takuro, Suzuki, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10360220/
https://www.ncbi.nlm.nih.gov/pubmed/37475037
http://dx.doi.org/10.1186/s13019-023-02310-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10360220/
https://www.ncbi.nlm.nih.gov/pubmed/37475037
http://dx.doi.org/10.1186/s13019-023-02310-5

Ejemplares similares